284 related articles for article (PubMed ID: 21475039)
1. Glut-1 expression and in situ CD1a/CD57 immunologic deficit in keratoacanthoma and squamous cell carcinoma of immunocompetent patients.
Cabibi D; Aragona F; Guarnotta C; Rodolico V; Zerilli M; Belmonte B; Schillaci L; Aragona F
Appl Immunohistochem Mol Morphol; 2011 May; 19(3):239-45. PubMed ID: 21475039
[TBL] [Abstract][Full Text] [Related]
2. CD1A-positive cells and HSP60 (HSPD1) levels in keratoacanthoma and squamous cell carcinoma.
Cabibi D; Conway de Macario E; Ingrao S; Porcasi R; Zucco F; Macario AJL; Cappello F; Rappa F
Cell Stress Chaperones; 2016 Jan; 21(1):131-137. PubMed ID: 26442925
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and follow-up of keratoacanthoma-like lesions: clinical-histologic study of 43 cases.
Magalhães RF; Cruvinel GT; Cintra GF; Cintra ML; Ismael AP; de Moraes AM
J Cutan Med Surg; 2008; 12(4):163-73. PubMed ID: 18627696
[TBL] [Abstract][Full Text] [Related]
4. p16 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.
Kaabipour E; Haupt HM; Stern JB; Kanetsky PA; Podolski VF; Martin AM
Arch Pathol Lab Med; 2006 Jan; 130(1):69-73. PubMed ID: 16390241
[TBL] [Abstract][Full Text] [Related]
5. [The value of laminin-322 staining in distinguishing between keratoacanthoma, keratoacanthoma with areas of squamous cell carcinoma, and crateriform squamous cell carcinoma].
Corbalán-Vélez R; Martínez-Barba E; López-Poveda MJ; Vidal-Abarca Gutiérrez I; Ruíz-Maciá JA; Oviedo-Ramirez I; Martínez-Menchón T
Actas Dermosifiliogr; 2012 May; 103(4):308-16. PubMed ID: 22176864
[TBL] [Abstract][Full Text] [Related]
6. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors.
Ogita A; Ansai SI; Misago N; Anan T; Fukumoto T; Saeki H
J Dermatol; 2016 Nov; 43(11):1321-1331. PubMed ID: 27076258
[TBL] [Abstract][Full Text] [Related]
7. Keratoacanthoma and Keratoacanthoma-Like Squamous Cell Carcinoma: Similar Morphology but Different Pathogenesis.
Watanabe IC; Magalhães RF; de Moraes AM; Stelini RF; Cintra GF; Metze K; Cintra ML
Medicine (Baltimore); 2015 Jun; 94(23):e934. PubMed ID: 26061320
[TBL] [Abstract][Full Text] [Related]
8. Invasive squamous cell carcinoma initially diagnosed as a giant keratoacanthoma.
Goldenhersh MA; Olsen TG
J Am Acad Dermatol; 1984 Feb; 10(2 Pt 2):372-8. PubMed ID: 6368620
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of S100 protein-positive cells in inflamed and non-inflamed keratoacanthoma and squamous cell carcinoma.
Korenberg R; Penneys NS; Kowalczyk A; Nadji M
J Cutan Pathol; 1988 Apr; 15(2):104-8. PubMed ID: 3372786
[TBL] [Abstract][Full Text] [Related]
10. Assessment of syndecan-1 (CD138) and Ki-67 expression for differentiating keratoacanthoma and squamous cell carcinoma.
Lammoglia-Ordiales L; Toussaint-Caire S; Contreras-Barrera M; Fonte-Avalos V; Rodriguez-Carreón AA; Rivera-Macias S; Dominguez-Cherit J
J Drugs Dermatol; 2013 Mar; 12(3):e53-8. PubMed ID: 23545927
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.
Krunic AL; Garrod DR; Madani S; Buchanan MD; Clark RE
Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833
[TBL] [Abstract][Full Text] [Related]
12. Is it skin cancer--or keratoacanthoma?
Greene SL; Perry HO
Geriatrics; 1984 Sep; 39(9):91-4, 98-9, 102. PubMed ID: 6468938
[No Abstract] [Full Text] [Related]
13. Pattern of TGFbeta receptor 1 expression differs between kras-mutated keratoacanthomas and squamous cell carcinomas of the skin.
Berger F; Geddert H; Faller G; Werner M; Dimmler A
Pathol Res Pract; 2014 Sep; 210(9):596-602. PubMed ID: 24954139
[TBL] [Abstract][Full Text] [Related]
14. Plasmacytoid dendritic cells in keratoacanthoma and squamous cell carcinoma: A blinded study of CD123 as a diagnostic marker.
Fraga GR; Chow P
J Cutan Pathol; 2020 Jan; 47(1):17-21. PubMed ID: 31449667
[TBL] [Abstract][Full Text] [Related]
15. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.
Mukunyadzi P; Sanderson RD; Fan CY; Smoller BR
Mod Pathol; 2002 Jan; 15(1):45-9. PubMed ID: 11796840
[TBL] [Abstract][Full Text] [Related]
16. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors.
Cain CT; Niemann TH; Argenyi ZB
Am J Dermatopathol; 1995 Aug; 17(4):324-31. PubMed ID: 8600793
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor 2 mRNA-binding protein-3 as a marker for distinguishing between cutaneous squamous cell carcinoma and keratoacanthoma.
Kanzaki A; Kudo M; Ansai S; Peng WX; Ishino K; Yamamoto T; Wada R; Fujii T; Teduka K; Kawahara K; Kawamoto Y; Kitamura T; Kawana S; Saeki H; Naito Z
Int J Oncol; 2016 Mar; 48(3):1007-15. PubMed ID: 26782292
[TBL] [Abstract][Full Text] [Related]
18. Estimation of the volume-weighted mean nuclear volume discriminates keratoacanthoma from squamous cell carcinoma.
Binder M; Steiner A; Mossbacher U; Hunegnaw M; Pehamberger H; Wolff K
Am J Dermatopathol; 1998 Oct; 20(5):453-8. PubMed ID: 9790104
[TBL] [Abstract][Full Text] [Related]
19. [A flow cytometric study of the DNA content from paraffin-embedded samples of keratoacanthoma and squamous cell carcinoma].
Hashimoto Y; Matsuo S; Iizuka H
Nihon Hifuka Gakkai Zasshi; 1991 Jun; 101(7):701-5. PubMed ID: 1942578
[TBL] [Abstract][Full Text] [Related]
20. Keratoacanthoma and other types of squamous cell carcinoma with crateriform architecture: classification and identification.
Misago N; Inoue T; Koba S; Narisawa Y
J Dermatol; 2013 Jun; 40(6):443-52. PubMed ID: 23414327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
